Dmitri Bobilev's most recent trade in Fusion Pharmaceuticals Inc was a trade of 151,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Fusion Pharmaceuticals Inc | Dmitri Bobilev | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 151,700 | 151,700 | - | - | Stock Option (Right to Buy) | |
Fusion Pharmaceuticals Inc | Dmitri Bobilev | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 91,000 | 91,000 | - | - | Restricted Stock Units | |
Fusion Pharmaceuticals Inc | Dmitri Bobilev | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 550,000 | 550,000 | - | - | Stock Option (Right to Buy) |